Ignite Creation Date:
2024-05-05 @ 6:32 PM
Last Modification Date:
2024-10-26 @ 9:34 AM
Study NCT ID:
NCT00494299
Status:
COMPLETED
Last Update Posted:
2013-12-20
First Post:
2007-06-28
Brief Title:
Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma HCC Treated After Transcatheter Arterial Chemoembolization TACE
Sponsor:
Bayer
Organization:
Bayer
Study Overview
Official Title:
Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma HCC Treated After Transcatheter Arterial Chemoembolization TACE
Status:
COMPLETED
Status Verified Date:
2013-11
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Clinical trial of BAY43-9006 in patients with hepatocellular carcinoma
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None